People: Cerus Corp (CERS.O)

CERS.O on Consolidated Issue listed on NASDAQ Global Market

26 Mar 2015
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Corash, Laurence 

Dr. Laurence M. Corash, M.D., is Senior Vice President, Chief Medical and Chief Scientific Officer, Director of Cerus Corporation. He is one of co-founders, has served as a member of Board since December 2002. The Nominating and Corporate Governance Committee concluded that Dr. Corash continues to be a member of the Board in part due to his knowledge of the company, having been a director since 2002, which brings historic knowledge and continuity to the Board. The Board also considered his scientific obtained from almost 30 years as an M.D. in the field of hematology, which is relevant to pathogen inactivation technology for blood products. Dr. Corash has been Senior Vice President and Chief Medical and Chief Scientific Officer since July 2009. Previously, he had been Senior Vice President and Chief Medical Officer since March 2008. Prior to that, he had been Vice President, Medical Affairs since July 1996 and Director of Medical Affairs from July 1994. Dr. Corash was a consultant to the company from 1991 until 1994, when he joined the company as Director, Medical Affairs. Dr. Corash has been a Professor of Laboratory Medicine at the University of California, San Francisco since July 1985 and continues to serve as an Attending Physician at the University of California Medical Center. He was the Chief of the Hematology Laboratory for the Medical Center at the University of California, San Francisco from 1982 to 1997. From February 1990 to July 1994, Dr. Corash was a member of the FDA Advisory Panel for Hematology Devices. Dr. Corash currently serves as the industry representative on the Department of Health and Human Services’ Advisory Committee on Blood Safety and Availability.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
488,240 -- 343,415 831,655

Options Compensation

  Quantity Market Value
Exercisable 281,619 546,323.00
Unexercisable 163,006 910,754.00
Exercised 35,000 57,970.00
Name Fiscal Year Total

Daniel Swisher


William Greenman


Kevin Green


Caspar Hogeboom


Laurence Corash


Carol Moore

As Of  30 Dec 2013
Search Stocks